The second vaccine, R21/Matrix-M, is highly effective, reducing cases of malaria by 75%. Hundreds of millions of doses of this vaccine can be produced each year. It will be ready for rollout as ...

The RTS,S construct formulated with the adjuvant AS02 gave approximately 50% protection from clinical malaria in a Phase IIa trial. Field trials ensued with an efficacy of 30–60% in a 6–12 ...

Malaria burden is the highest on the African continent, which accounts for approximately 95% of global malaria cases and 96 ...

The number of malaria cases rose again in 2022, propelled by flooding and warmer weather in areas once free of the illness.

As the clock ticked toward midnight on the night of Nov. 21 in Yaoundé, Cameroon, aid workers began unloading 331,200 doses ...

Health Sector Performance Report for 2022/2023 revealed major causes of deaths, with malaria on top, accounting for 4,245 ...

In a statement, WHO Director-General Tedros Adhanom Ghebreyesus, PhD, said, "The changing climate poses a substantial risk to ...

Climate change and its impacts, particularly extreme weather and heatwaves, pose a “substantial risk” to progress being made ...

Children below two years in Cameroon will soon receive shots of Mosquirix, the first-ever Malaria vaccine acquired by the ...

GENEVA, Dec 1 (NNN-AGENCIES) - Climate change is making the fight against malaria even harder, with the campaign already ...

There were more than 249 million malaria cases globally in 2022, which is more than pre-pandemic. | ITV National News ...

Climate change is making the fight against malaria even harder, with the campaign already struggling to make up ground lost ...